Busulfan-Cyclophosphamide versus Cyclophosphamide-Busulfan as conditioning regimen before allogeneic hematopoietic cell transplantation: a prospective randomized trial

被引：0
|
作者：
Seydoux, C. [1 ]
Medinger, M. [1 ]
Gerull, S. [1 ]
Halter, J. [1 ]
Heim, D. [1 ]
Chalandon, Y. [2 ,3 ]
Levrat, Masouridi S. [2 ,3 ]
Schanz, U. [4 ]
Nair, G. [4 ]
Simon, P. [5 ]
Passweg, J. R. [1 ]
Cantoni, N. [6 ]
机构：
[1] Univ Hosp Basel, Div Hematol, Basel, Switzerland
[2] Univ Hosp Geneva, Bone Marrow Transplant Unit, Div Hematol, Geneva, Switzerland
[3] Univ Geneva, Fac Med, Geneva, Switzerland
[4] Univ Zurich, Stem Immune Cell Transplant Unit, Dept Med Oncol & Hematol, Zurich, Switzerland
[5] Basel Univ, Dept Clin Res, Clin Trials Unit, Basel, Switzerland
[6] Kantonsspital Aarau, Div Oncol Hematol & Transfus Med, Aarau, Switzerland
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2020年 / 43卷 / SUPPL 4期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10
引用
收藏
页码：45 / 46
页数：2
相关论文
共 50 条
  • [41] Busulfan Fludarabine Vs. Busulfan Cyclophosphamide As a Preparative Regimen Prior to Allogeneic Hematopoietic Cell Transplantation - Systematic Review and Meta-analysis
    Ben Barouch, Sharon
    Cohen, Omri
    Vidal, Liat
    Avivi, Irit
    Ram, Ron
    BLOOD, 2014, 124 (21)
  • [42] MYELOABLATIVE CONDITIONING REGIMEN WITH INTRAVENOUS VERSUS ORAL BUSULFAN PLUS CYCLOPHOSPHAMIDE: THE ROLE OF THE CYCLOPHOSPHAMIDE DOSE
    Yakoub-Agha, I.
    Parent, D.
    Damaj, G.
    Leroy-Cotteau, A.
    Magro, L.
    Coiteux, V.
    Yilmaz, M.
    Jouet, J. P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 568 - 568
  • [43] Myeloablative conditioning regimen with intravenous versus oral busulfan plus cyclophosphamide: role of cyclophosphamide dose
    Parent, D.
    Damaj, G.
    Leroy-Cotteau, A.
    Tresch, E.
    Coiteux, V.
    Terriou, L.
    Jouet, J. -P.
    Yilmaz, M.
    Yakoub-Agha, I.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S89 - S90
  • [44] Busulfan plus fludarabine as a myeloablative conditioning regimen compared with busulfan plus cyclophosphamide for acute myeloid leukemia in first complete remission undergoing allogeneic hematopoietic stem cell transplantation: a prospective and multicenter study
    Liu, Hui
    Zhai, Xiao
    Song, Zhaoyang
    Sun, Jing
    Xiao, Yang
    Nie, Danian
    Zhang, Yu
    Huang, Fen
    Zhou, Hongsheng
    Fan, Zhiping
    Tu, Sanfang
    Li, Yonghua
    Guo, Xutao
    Yu, Guopan
    Liu, Qifa
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2013, 6
  • [45] Busulfan plus fludarabine as a myeloablative conditioning regimen compared with busulfan plus cyclophosphamide for acute myeloid leukemia in first complete remission undergoing allogeneic hematopoietic stem cell transplantation: a prospective and multicenter study
    Hui Liu
    Xiao Zhai
    Zhaoyang Song
    Jing Sun
    Yang Xiao
    Danian Nie
    Yu Zhang
    Fen Huang
    Hongsheng Zhou
    Zhiping Fan
    Sanfang Tu
    Yonghua Li
    Xutao Guo
    Guopan Yu
    Qifa Liu
    Journal of Hematology & Oncology, 6
  • [46] Role of pharmacogenetics in busulfan/cyclophosphamide conditioning therapy prior to hematopoietic stem cell transplantation
    Hassan, Moustapha
    Andersson, Borje S.
    PHARMACOGENOMICS, 2013, 14 (01) : 75 - 87
  • [47] Association of Busulfan and Cyclophosphamide Conditioning with Sleep Disorders after Hematopoietic Stem Cell Transplantation
    Faulhaber, Gustavo A. M.
    Furlanetto, Tania W.
    Astigarraga, Claudia C.
    Moser Filho, Humberto Luiz
    Paludo, Angela Paula
    Silla, Lucia M. R.
    ACTA HAEMATOLOGICA, 2010, 124 (02) : 125 - 128
  • [48] Decitabine with cyclophosphamide and busulfan as a preparative regimen for allogeneic transplantation: Results of a phase I trial.
    Rivandi, F
    Kantarjian, H
    Davis, M
    Anderlini, P
    Donato, M
    Khouri, I
    DiMartino, J
    Champlin, R
    Giralt, S
    BLOOD, 2000, 96 (11) : 393A - 393A
  • [49] Clinical outcome of allogeneic hematopoietic stem cell transplantation with FLAG sequential busulfan/cyclophosphamide conditioning regimen for refractory/relapsed acute myeloid leukemia
    刘微
    ChinaMedicalAbstracts(InternalMedicine), 2018, 35 (03) : 186 - 186
  • [50] Comparison of TBI versus busulfan in combination with cyclophosphamide as conditioning regimen for unrelated stem cell transplantation in CML patients
    Zabelina, T
    Kröger, N
    Krueger, W
    Renges, H
    Kabisch, H
    Zander, AR
    BONE MARROW TRANSPLANTATION, 2001, 27 : S144 - S144
12345